SciMax Global Receives Frost & Sullivan’s 2026 Global Enabling Technology Leadership Recognition for Digital Medical Affairs Solutions
Recognition highlights SciMax’s AI-native platform, agentic AI capabilities, integrated architecture, and customer-driven innovation model transforming Medical Affairs operation
Princeton, New Jersey – 7th October, 2026. SciMax Global has been recognized with Frost & Sullivan’s 2026 Global Enabling Technology Leadership Recognition for its strong overall performance in the global digital medical affairs solutions industry.
The recognition underscores SciMax’s ability to apply advanced technologies in new ways to transform complex Medical Affairs workflows, improve operational efficiency, support compliant scientific engagement, and create scalable technology foundations for life sciences organizations.
Frost & Sullivan’s evaluation recognizes organizations that leverage technology to improve existing products and services while elevating the customer experience. Its assessment of SciMax highlights the company’s purpose-built Medical Affairs platform, AI-native architecture, agentic AI framework, configurable global deployment model, integrated platform design, and strategic innovation partnership approach.
“SciMax designs its platform specifically for medical affairs rather than adapting a generic CRM, custom cloud, or crossindustry workflow system. This verticalized approach reflects a deep understanding of regulated scientific workflows, where accuracy, consistency, auditability, and regional compliance are essential.” Stated Rabin Dhakal, Best Practices Research Analyst. “SciMax further differentiates itself through its unified data model and centralized configuration approach. The company configures core scientific content, product information, and process frameworks and utilizes them across global operations, while still allowing for necessary localization aligned with regional regulatory standards and language requirements.” Said Surbhi Gupta, Industry Principal, GOA
“The evolution of Medical Affairs is increasingly being shaped by the convergence of domain expertise, intelligent automation, and artificial intelligence. SciMax Global is demonstrating how this convergence can be translated into practical, scalable solutions for life sciences organizations. Its AI-native platform and agentic AI capabilities, coupled with a strong focus on customer collaboration and global deployment, provide a differentiated approach to addressing the complexity of modern Medical Affairs operations.” Stated Shekar Gopalan, Senior Partner, North America, Frost & Sullivan. He added, “Frost & Sullivan’s recognition reflects SciMax’s ability to leverage technology not simply to digitize existing processes, but to fundamentally enhance how Medical Affairs workflows are executed and managed.”
Expressing his pleasure, SciMax Global CEO Satya Sagi remarked “We are honored to receive Frost & Sullivan’s 2026 Global Enabling Technology Leadership Recognition. This recognition validates our vision of transforming Medical Affairs through purpose-built technology, intelligent automation, and AI-native workflows.
Medical Affairs organizations should not have to choose between innovation and compliance, or between global standardization and local flexibility. SciMax is built to bring these priorities together in a single, connected technology ecosystem. Through our platform and ARIN’s agentic AI capabilities, we are moving beyond simply digitizing workflows toward enabling intelligent workflow execution—while keeping scientific integrity, governance, and human oversight at the center.”
“At SciMax, our goal has always been to build technology that goes beyond digitizing Medical Affairs—we want to fundamentally improve how Medical Affairs teams work.” Adds Saad Rahman, Chief Product Officer, SciMax Global. Speaking about Scimax products, he mentions, “Our unified platform and SCIMAX ARIN bring intelligent automation and agentic AI into real-world workflows while maintaining the scientific rigor, human oversight, and compliance that the industry demands. Being recognized by Frost & Sullivan validates this product vision and our commitment to helping life sciences organizations operate more intelligently, efficiently, and at global scale.”
To access the Frost and Sullivan Enabling Technology Leadership assessment report, click here.
For media inquiries, please contact
Rajarshi Mukherjee,
Associate Director – Digital Marketing, SciMax Global.
Email: rajarshi.mukherjee@Scimaxglobal.com
About SciMax Global
SciMax Global is a technology company dedicated exclusively to advancing scientific communications and Medical Affairs within the pharmaceutical and life sciences sectors.
Its unified, cloud-based platform brings together multiple Medical Affairs programs in a cohesive and scalable environment, supporting organizations across Medical Information, scientific publications, collaboration, investigator-initiated research, sponsorship and grants, expanded access, and related workflows.
SciMax combines domain-specific workflow capabilities, configurable global deployment, embedded compliance controls, automation, analytics, and agentic AI through SciMax ARIN to help life sciences organizations transform complex Medical Affairs operations.
With a focus on scientific precision, operational efficiency, global scalability, and customer-driven innovation, SciMax is advancing the transition toward an AI-native Medical Affairs operating model.
About Frost & Sullivan
Frost & Sullivan is a growth-focused research and advisory organization with more than 60 years of experience supporting organizations across industries and geographies. Its Best Practices Recognition program evaluates companies against rigorous criteria designed to identify organizations demonstrating outstanding performance and leadership in their respective markets.
For the Enabling Technology Leadership Recognition, Frost & Sullivan evaluates criteria across dimensions including Technology Leverage and Customer Impact, covering areas such as commitment to innovation and creativity, stage-gate efficiency, commercialization, application diversity, price/performance value, customer experience, customer ownership, service experience, and brand equity.
